Our sincere congratulations to Prof. Gloria Färber, PD Dr. med. Arnaud Van Linden and their team at the Universitätsklinikum Würzburg on the first implantation of the Neo EDE Hybrid Arch Device with outer branches which was performed in Germany. We are proud to be leading the way in aortic arch solutions, thanks to our great partners. Learn more today: https://bit.ly/3HRwXx3 #ArtivionEMEA #FET #cardiovascular
Artivion EMEA
Herstellung medizinischer Geräte
Hechingen, Baden-Württemberg 13.181 Follower:innen
Advancing Aortic Technologies With Purpose™
Info
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.
- Website
-
http://www.artivion.com
Externer Link zu Artivion EMEA
- Branche
- Herstellung medizinischer Geräte
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Hechingen, Baden-Württemberg
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1984
Orte
-
Primär
Lotzenäcker 23
Hechingen, Baden-Württemberg 72379, DE
Beschäftigte von Artivion EMEA
-
Jorrit Stolwijk
Simplify the complex in Aortic Surgery, improving outcomes for patients
-
Rob de Wilde
Country Manager BeNeLux at Artivion
-
Stefan Menzl
Vice President EMEA, Regulatory Affairs & Quality, Artivion Managing challenging requirements pragmatically...
-
Volker K.E. Böhm
Sales Manager Schweiz bei JOTEC Sales GmbH a fully owned subsidiary of Artivion, Inc.
Updates
-
We’re proud to share that Prof. Tomas Holubec, MD, PhD (Frankfurt, Germany) successfully performed a 𝐥𝐢𝐯𝐞 𝐜𝐚𝐬𝐞 using our E-vita Open Neo during the 3rd EACTS - European Association for Cardio-Thoracic Surgery - 𝐓𝐡𝐞 𝐀𝐨𝐫𝐭𝐢𝐜 𝐅𝐨𝐫𝐮𝐦 in Prague, Czech Republic. 📍 Live from Cardiac Centre, IK+EM, Prague, the procedure was broadcast to a global audience of clinicians and peers, highlighting the real-world impact and innovation behind our FET technology. Professor T. Holubec demonstrated how the trifurcated configuration of the E-vita Open Neo in Zone 0 facilitates minimally invasive surgery, offering valuable insights into advanced patient care and the role of our technology in enabling precision and confidence during complex cases. A huge thank you to Professor T. Holubec for sharing his insights and experience. Want to learn more? https://bit.ly/3PqhSTg #FET #LiveSurgery #AorticArchRepair #ArtivionEMEA
-
As world leaders in aortic arch solutions, we’ve spent the past 20 years advancing frozen elephant trunk repair through close collaboration and continuous innovation. We are deeply grateful for the trust and partnership of surgeons around the world, because only together can we fulfill our mission: to restore the health of patients by delivering innovative technologies of unsurpassed quality. United in purpose, we are redefining how cutting-edge solutions improve outcomes for patients everywhere. Learn more about our newest innovation: https://bit.ly/3HRwXx3 #FET #ArtivionEMEA #cardiovascular
-
Our sincere congratulations to Prof. Maximilian Pichlmaier and Prof. Sven Peterss on the world’s first implantation of the Neo EDE Hybrid Arch Device with two inner branches, successfully performed at LMU Klinikum in Munich. The underlying concept for the inner branch approach was developed by Prof. Pichlmaier and Prof. Peterß, contributing to ongoing innovation in the field. 👏 With five cases successfully completed, this represents an important step forward for the program and offers new treatment options in cardiac surgery. “𝐖𝐞 𝐚𝐫𝐞 𝐝𝐞𝐥𝐢𝐠𝐡𝐭𝐞𝐝 𝐭𝐡𝐚𝐭 𝐨𝐮𝐫 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐝 𝐞𝐟𝐟𝐨𝐫𝐭𝐬 𝐭𝐨 𝐝𝐞𝐯𝐞𝐥𝐨𝐩 𝐅𝐄𝐓 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐟𝐮𝐫𝐭𝐡𝐞𝐫, 𝐢𝐧 𝐜𝐥𝐨𝐬𝐞 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐀𝐫𝐭𝐢𝐯𝐢𝐨𝐧, 𝐧𝐨𝐰 𝐫𝐞𝐬𝐮𝐥𝐭𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐜𝐞𝐧𝐭 𝐢𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐚 𝐜𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥𝐥𝐲 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐞𝐧𝐚𝐛𝐥𝐢𝐧𝐠 𝐥𝐞𝐬𝐬 𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐥𝐚𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐝𝐢𝐬𝐭𝐚𝐥 𝐚𝐧𝐚𝐬𝐭𝐨𝐦𝐨𝐬𝐢𝐬 𝐢𝐧 𝐳𝐨𝐧𝐞 𝟎. 𝐀𝐥𝐥 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐭𝐫𝐞𝐚𝐭𝐞𝐝 𝐬𝐨 𝐟𝐚𝐫 – 𝐬𝐞𝐯𝐞𝐧 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐩𝐡𝐚𝐬𝐞 𝐢𝐧 𝟐𝟎𝟐𝟏 𝐚𝐧𝐝 𝐟𝐢𝐯𝐞 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐝𝐞𝐯𝐢𝐜𝐞 – 𝐚𝐫𝐞 𝐚𝐥𝐢𝐯𝐞 𝐚𝐧𝐝 𝐝𝐨𝐢𝐧𝐠 𝐰𝐞𝐥𝐥, 𝐬𝐡𝐨𝐰𝐢𝐧𝐠 𝐯𝐞𝐫𝐲 𝐬𝐚𝐭𝐢𝐬𝐟𝐚𝐜𝐭𝐨𝐫𝐲 𝐩𝐨𝐬𝐭-𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬.” – 𝐏𝐫𝐨𝐟. 𝐌. 𝐏𝐢𝐜𝐡𝐥𝐦𝐚𝐢𝐞𝐫 The Neo EDE Hybrid Arch Device allows for individualized adaptation to each patient’s anatomy, supporting more targeted and patient-specific care. Learn more today: https://bit.ly/3HRwXx3 #ArtivionEMEA #FET #cardiovascular
-
Congratulations to Prof. Michele Antonello, Prof. Michele Piazza M.D., and Dr. Andrea Spertino and the full team of the Vascular Surgery of Padua Directed by Prof. Franco Grego for successfully implanting the first NEXUS TRE™ in Italy! We're honored to support your dedication to advancing aortic technology with purpose. #ArtivionEMEA #NEXUS #Aorticarch
-
Are you attending #ECSC2025? This year the Endoscopic Cardiac Surgeons Club meeting is being held in the US in Cincinnati / Northern Kentucky September 4-6th. 👉 Register today: https://bit.ly/4kEL5Yy Artivion will be hosting an ELITE Learning Lab on minimally-invasive surgical techniques as well as a Breakfast Symposium: Shifting Tides – The Rise of the Mechanical Valve: Aortic & Mitral Valve Management in Patients < 65. See you in Cincinnati!!
-
-
🎉 Celebrating 25 Years of Innovation, Impact, and Teamwork in Hechingen! 🎉 What began as a dedicated medical technology team in the year 2000 in the heart of south Germany evolved into a global company when Jotec joined CryoLife in 2017. In 2022, we proudly became Artivion — uniting our passion for aortic and cardiac innovation under one strong global brand. 💙 A heartfelt thank you goes out to all our employees, business partners, surgeons, and healthcare professionals around the world. Your trust, dedication, and collaboration have been essential to our success. Together, we’ve grown, evolved, and made a difference — and we’re just getting started. #WeAreArtivion #25Years #ArtivionEMEA #Milestone
-
-
Do you want to learn more about the step-by-step process of an E-xtra Design MultiBranch procedure? Don´t miss out on our new product animation video: https://lnkd.in/dsatk3k4 Not all products and indications are available/approved in all markets. #ArtivionEMEA #TAAA #Endovascular
-
Congratulations to Dr. Adrien Kaladji and Dr. Jacques Tomasi for implanting the first NEXUS TRE™ in France. We're proud to support your commitment to advancing aortic technologies with purpose. #ArtivionEMEA #NEXUS #AorticArch
-
🎥 Missed the live session? No problem — it’s now available on demand! Our webinar, NEXUS TRE: A new solution for the total endovascular aortic arch repair, is now ready for you to watch at your convenience. Hosted by: Timothy Resch Speakers: Theodosios Bisdas, MD, PhD, FACS, Said Abisi, and Augusto D'Onofrio. 📺 Watch it now, anytime: https://lnkd.in/d_Sru3wM #ArtivionEMEA #AorticArch #Endovascular
-